HCA Healthcare Inc (NYSE: HCA) has a higher price-to-earnings ratio of 16.75x compared to its average ratio, The 36-month beta value for HCA is at 1.50. Analysts have varying views on the stock, with 13 analysts rating it as a “buy,” 2 rating it as “overweight,” 9 as “hold,” and 0 as “sell.”
The public float for HCA is 170.53M, and currently, shorts hold a 2.61% of that float. The average trading volume for HCA on June 20, 2025 was 1.55M shares.
HCA) stock’s latest price update
The stock of HCA Healthcare Inc (NYSE: HCA) has increased by 1.18 when compared to last closing price of 372.45.Despite this, the company has seen a gain of 2.52% in its stock price over the last five trading days. zacks.com reported 2025-06-19 that Whether you’re a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
HCA’s Market Performance
HCA’s stock has risen by 2.52% in the past week, with a monthly drop of -2.59% and a quarterly rise of 12.77%. The volatility ratio for the week is 0.91% while the volatility levels for the last 30 days are 1.10% for HCA Healthcare Inc The simple moving average for the last 20 days is 0.08% for HCA’s stock, with a simple moving average of 8.12% for the last 200 days.
Analysts’ Opinion of HCA
Many brokerage firms have already submitted their reports for HCA stocks, with Wells Fargo repeating the rating for HCA by listing it as a “Equal Weight.” The predicted price for HCA in the upcoming period, according to Wells Fargo is $385 based on the research report published on May 29, 2025 of the current year 2025.
Robert W. Baird, on the other hand, stated in their research note that they expect to see HCA reach a price target of $336. The rating they have provided for HCA stocks is “Neutral” according to the report published on April 15th, 2025.
JP Morgan gave a rating of “Neutral” to HCA, setting the target price at $380 in the report published on December 17th of the previous year.
HCA Trading at 4.75% from the 50-Day Moving Average
After a stumble in the market that brought HCA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -9.66% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at HCA starting from Foster Jon M, who sale 15,698 shares at the price of $369.32 back on May 13 ’25. After this action, Foster Jon M now owns 12,646 shares of HCA Healthcare Inc, valued at $5,797,661 using the latest closing price.
Foster Jon M, the Officer of HCA Healthcare Inc, proposed sale 15,698 shares at $369.32 during a trade that took place back on May 13 ’25, which means that Foster Jon M is holding shares at $5,797,660 based on the most recent closing price.
Stock Fundamentals for HCA
Current profitability levels for the company are sitting at:
- 0.15 for the present operating margin
- 0.68 for the gross margin
The net margin for HCA Healthcare Inc stands at 0.08. The total capital return value is set at 0.23.
Based on HCA Healthcare Inc (HCA), the company’s capital structure generated 1.08 points at debt to capital in total, while cash flow to debt ratio is standing at 0.21. The debt to equity ratio resting at -13.2. The interest coverage ratio of the stock is 5.17.
Currently, EBITDA for the company is 13.9 billion with net debt to EBITDA at 3.23. When we switch over and look at the enterprise to sales, we see a ratio of 1.9. The receivables turnover for the company is 6.46for trailing twelve months and the total asset turnover is 1.2. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.19.
Conclusion
In conclusion, HCA Healthcare Inc (HCA) has had a better performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
